Structures by: Srinivasan N.
Total: 87
Ethyl 6'-cyano-7'-(<i>p</i>-tolyl)-1',6',7',7a'-tetrahydro-3'<i>H</i>-spiro[indeno[1,2-<i>b</i>]quinoxaline-11,5'-pyrrolo[1,2-<i>c</i>]thiazole]-6'-carboxylate
C31H26N4O2S
IUCrData (2019) 4, 1 x190010
a=10.5467(17)Å b=11.6469(19)Å c=12.942(2)Å
α=108.321(3)° β=102.108(3)° γ=110.887(3)°
Ethyl 6'-cyano-7'-phenyl-1',6',7',7a'-tetrahydro-3'<i>H</i>-spiro[indeno[1,2-<i>b</i>]quinoxaline-11,5'-pyrrolo[1,2-<i>c</i>]thiazole-6'-carboxylate
C30H24N4O2S
IUCrData (2018) 3, 9 x181286
a=18.6131(13)Å b=18.2243(13)Å c=15.8867(11)Å
α=90° β=110.7570(10)° γ=90°
2-[(4-Chlorophenyl)(2-phenyl-1<i>H</i>-indol-3-yl)methyl]cyclohexan-1-one
C27H24ClNO
IUCrData (2016) 1, 4 x160644
a=7.2562(2)Å b=16.4818(5)Å c=18.0306(6)Å
α=90° β=95.149(2)° γ=90°
9-Fluoro-2,4,4a,6-tetrahydrospiro[benzo[<i>c</i>]chromene-3,2'-[1,3]dioxolane]
C15H15FO3
IUCrData (2017) 2, 1 x170045
a=7.0373(4)Å b=20.7068(14)Å c=8.4725(6)Å
α=90° β=92.088(3)° γ=90°
(c10H10S2N1)2,hg2,(c5h4N)1
(c10H10S2N1)2,hg2,(c5h4N)1
RSC Adv. (2014) 4, 44 22971
a=8.696(1)Å b=10.994(1)Å c=14.457(1)Å
α=84.01(1)° β=87.05(1)° γ=70.49(1)°
(c10H10NS21)2,Hg2,(c2H6o1)0.25
(c10H10NS21)2,Hg2,(c2H6o1)0.25
RSC Adv. (2014) 4, 44 22971
a=16.7060(10)Å b=7.3860(10)Å c=19.9140(10)Å
α=90.00° β=96.898(4)° γ=90.00°
(c10N1S21)3,(Hg1.52),(c2.5h2.5n0.5)1
(c10N1S21)3,(Hg1.52),(c2.5h2.5n0.5)1
RSC Adv. (2014) 4, 44 22971
a=8.899(1)Å b=10.782(1)Å c=18.880(1)Å
α=74.64(1)° β=77.36(1)° γ=87.72(1)°
Diethyl 1-(4-chlorobenzyl)-4-(4-chlorophenyl)-2,2-dioxo-3,4,6,7,8,8a-hexahydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]thiazine-1,3-dicarboxylate
C26H29Cl2NO6S
Acta Crystallographica Section E (2018) 74, 9 1267-1271
a=11.6596(4)Å b=14.5734(4)Å c=15.7000(5)Å
α=90° β=104.635(2)° γ=90°
Diethyl 1-(4-methylbenzyl)-4-(4-methylphenyl)-2,2-dioxo-3,4,6,7,8,8a-hexahydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]thiazine-1,3-dicarboxylate
C28H35NO6S
Acta Crystallographica Section E (2018) 74, 9 1267-1271
a=11.8641(5)Å b=14.4765(6)Å c=15.8654(7)Å
α=90° β=104.960(2)° γ=90°
2'-(4-Bromobenzoyl)-1'-(2-chlorophenyl)-1,1',2,2',5',6',7',7a'-octahydrospiro[indole-3,3'-pyrrolizin]-2-one
C27H22BrClN2O2
Acta Crystallographica Section E (2016) 72, 11 1637-1641
a=10.7280(4)Å b=9.7793(4)Å c=22.6746(9)Å
α=90° β=98.9720(10)° γ=90°
2'-Benzoyl-1'-(4-methylphenyl)-1,1',2,2',5',6',7',7a'-octahydrospiro[indole-3,3'-pyrrolizin]-2-one
C28H26N2O2
Acta Crystallographica Section E (2016) 72, 11 1637-1641
a=36.030(2)Å b=24.2248(16)Å c=10.1301(6)Å
α=90° β=90° γ=90°
<i>trans</i>-Bis[μ-2-(1,3-benzothiazol-2-yl)phenolato]-κ^3^<i>N</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>N</i>,<i>O</i>-bis[<i>fac</i>-tricarbonylrhenium(I)]
C32H16N2O8Re2S2
Acta Crystallographica Section E (2017) 73, 2 310-313
a=8.9250(11)Å b=9.7342(12)Å c=10.0844(12)Å
α=66.438(5)° β=75.636(5)° γ=63.585(5)°
<i>cis</i>-Bis[μ-2-(1,3-benzothiazol-2-yl)phenolato]-κ^3^<i>N</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>N</i>,<i>O</i>-bis[<i>fac</i>-tricarbonylrhenium(I)]
C32H16N2O8Re2S2
Acta Crystallographica Section E (2017) 73, 2 310-313
a=16.1480(7)Å b=11.6519(5)Å c=15.6329(8)Å
α=90° β=90° γ=90°
6a,6b,7,11a-Tetrahydro-6<i>H</i>,9<i>H</i>-spiro[chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazole-11,3'-indoline]-2',6-dione
C20H16N2O3S
Acta Crystallographica Section E (2019) 75, 2 246-250
a=11.3058(9)Å b=10.0905(8)Å c=15.1957(12)Å
α=90° β=101.0720(10)° γ=90°
5'-Methyl-6a,6b,7,11a-tetrahydro-6<i>H</i>,9<i>H</i>-spiro[chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazole-11,3'-indoline]-2',6-dione
C21H18N2O3S
Acta Crystallographica Section E (2019) 75, 2 246-250
a=8.3648(5)Å b=9.7648(6)Å c=11.9677(7)Å
α=112.6220(10)° β=99.3880(10)° γ=91.8850(10)°
5''-(2-Chlorobenzylidene)-4'-(2-chlorophenyl)-1'-methyldispiro[acenaphthene-1,2'-pyrrolidine-3',3''-piperidine]-2,4''-dione
C34H28Cl2N2O2
Acta Crystallographica Section E (2019) 75, 10 1456-1462
a=8.6710(4)Å b=15.6756(7)Å c=20.2284(9)Å
α=90° β=93.036(2)° γ=90°
2-Hydroxy-2-(2-oxocycloheptyl)-2,3-dihydro-1<i>H</i>-indene-1,3-dione
C16H16O4
Acta Crystallographica Section E (2015) 71, 10 o715-o716
a=7.4131(5)Å b=18.8596(13)Å c=19.0166(13)Å
α=90° β=90° γ=90°
Benzimidazole
C13H10N2O
Acta Crystallographica Section E (2014) 70, 2 o184
a=16.864(4)Å b=4.7431(8)Å c=12.952(2)Å
α=90° β=102.34(2)° γ=90°
N-(β-Carboxyethyl)-α-isoleucine
C9H18N2O3
Acta Crystallographica Section E (2015) 71, 9 o665-o666
a=5.2996(5)Å b=9.0053(7)Å c=23.211(2)Å
α=90° β=90° γ=90°
5-Benzoyl-2,4-diphenyl-4,5-dihydrofuran-3-carbonitrile
C24H17NO2
Acta Crystallographica Section E (2015) 71, 9 o663-o664
a=10.0704(7)Å b=15.7994(12)Å c=11.8632(9)Å
α=90° β=98.886(3)° γ=90°
Bis(L-glutamic acid) sulfate hemihydrate
2C5H10N1O41,SO42,0.5H2O
Acta Crystallographica Section E (2002) 58, 3 o272-o276
a=12.536(2)Å b=12.596(2)Å c=13.306(2)Å
α=79.090(10)° β=62.050(10)° γ=65.880(10)°
Bis(L-aspartic acid) nitrate
C4H8NO41,NO31,C4H7NO4
Acta Crystallographica Section E (2002) 58, 12 o1372-o1374
a=5.5840(7)Å b=11.491(3)Å c=21.043(5)Å
α=90.00° β=90.00° γ=90.00°
DL-valinium perchlorate
C5H12NO21,ClO41
Acta Crystallographica Section E (2003) 59, 1 o28-o30
a=10.3005(6)Å b=13.0905(8)Å c=14.6105(9)Å
α=81.288(2)° β=88.4473(19)° γ=75.9648(19)°
DL-valinium nitrate
C5H12NO21,NO31
Acta Crystallographica Section E (2002) 58, 2 o95-o97
a=9.5695(10)Å b=11.2104(16)Å c=17.537(3)Å
α=108.52(3)° β=104.14(2)° γ=90.25(2)°
Bis(L-tyrosinium)sulfate monohydrate
2C9H12NO31,O4S2,H2O
Acta Crystallographica Section E (2002) 58, 2 o211-o214
a=13.473(2)Å b=6.1340(10)Å c=13.785(3)Å
α=90.00° β=109.51(2)° γ=90.00°
L-citrullinium perchlorate
C6H14N3O31,ClO41
Acta Crystallographica Section E (2002) 58, 10 o1177-o1179
a=5.11130(10)Å b=11.3497(2)Å c=19.3853(3)Å
α=90.00° β=90.00° γ=90.00°
L-argininium chloride
C6H15N4O21,Cl1
Acta Crystallographica Section E (2002) 58, 7 o747-o749
a=5.1263(8)Å b=9.4610(10)Å c=10.322(2)Å
α=88.138(5)° β=76.447(4)° γ=89.745(5)°
Bis(D-phenylglycinium)sulfate monohydrate
2C8H10NO21,SO42,H2O
Acta Crystallographica Section E (2001) 57, 8 o754-o756
a=12.3201(12)Å b=5.9377(15)Å c=14.2908(16)Å
α=90.000(14)° β=111.369(10)° γ=90.000(13)°
Hydrogen bis[L-lysinium(2+)] dichloride perchlorate
C6H15N2O21,C6H16N2O22,ClO4,2Cl
Acta Crystallographica Section E (2001) 57, 9 o875-o877
a=5.0264(6)Å b=20.822(2)Å c=20.897(2)Å
α=90.00° β=90.00° γ=90.00°
Bis(DL-phenylalaninium)sulfate monohydrate
2C9H12NO21,O4S2,H2O
Acta Crystallographica Section E (2001) 57, 8 o772-o774
a=14.560(2)Å b=6.6000(12)Å c=22.115(4)Å
α=90.00° β=90.70(2)° γ=90.00°
Bis(L-histidinium sulfate) trihydrate
2C6H11N3O22,2S1O42,3H2O
Acta Crystallographica Section E (2001) 57, 7 o607-o609
a=8.3400(13)Å b=8.9291(11)Å c=10.724(2)Å
α=102.576(13)° β=107.704(15)° γ=119.667(11)°
Bis(L-threoninium)sulfate monohydrate
2C4H10NO31,SO42,H2O
Acta Crystallographica Section E (2001) 57, 7 o581-o583
a=23.096(4)Å b=6.281(9)Å c=11.6480(10)Å
α=90.00° β=116.122(9)° γ=90.00°
Bis(DL-aspartic acid) sulfate
2C4H8NO41,SO42
Acta Crystallographica Section E (2001) 57, 8 o679-o681
a=16.774(4)Å b=5.9697(9)Å c=14.5276(18)Å
α=90.00° β=98.66(2)° γ=90.00°
Bis( L-Lysinium(+)) hydrogen dichloride nitrate
2C6H15N2O21,H1,NO31,2Cl1
Acta Crystallographica Section E (2001) 57, 9 o888-o890
a=4.9846(2)Å b=20.604(2)Å c=20.663(2)Å
α=90.00° β=90.00° γ=90.00°
Bis(β-Alanine) H+ nitrate
2C3H7NO2,H1,NO31
Acta Crystallographica Section E (2001) 57, 11 o1004-o1006
a=19.7910(10)Å b=5.3220(3)Å c=10.9740(10)Å
α=90.00° β=113.923(6)° γ=90.00°
L-Phenylalanine--nitric acid (2/1)
2C9H11NO2,H1,NO31
Acta Crystallographica Section E (2001) 57, 10 o916-o918
a=12.536(16)Å b=5.378(4)Å c=14.962(9)Å
α=90.00° β=107.83(8)° γ=90.00°
Tri(L-Isoleucinium) sulfate bisulfate
3C6H14NO2,H1S1O4,S1O42
Acta Crystallographica Section E (2001) 57, 6 o558-o560
a=6.743(5)Å b=19.418(5)Å c=22.095(5)Å
α=90° β=90° γ=90°
Bis(DL-Methioninium)sulfate
2C5H12NO2S1,SO42
Acta Crystallographica Section E (2001) 57, 8 o746-o748
a=10.281(3)Å b=10.281(3)Å c=14.788(6)Å
α=90.00° β=90.00° γ=120.00°
L-methionine L-methioninium perchlorate monohydrate
C5H12NO2S1,ClO41,C5H11NO2S,H2O
Acta Crystallographica Section E (2002) 58, 7 o779-o781
a=11.3720(15)Å b=5.5876(8)Å c=15.323(2)Å
α=90.00° β=107.782(5)° γ=90.00°
DL-phenylalaninium nitrate
C9H12NO2,NO3
Acta Crystallographica Section E (2002) 58, 10 o1103-o1105
a=12.005(7)Å b=5.758(2)Å c=16.250(9)Å
α=90.00° β=107.48(6)° γ=90.00°
L-aspartic acid monohydrate
C4H7NO4,H2O
Acta Crystallographica Section E (2003) 59, 7 o1073-o1075
a=5.587(4)Å b=9.822(5)Å c=11.813(9)Å
α=90.00° β=90.00° γ=90.00°
1-Cyclohexyl-3-phenyl thiourea
C13H18N2S
Acta Crystallographica Section C (1996) 52, 3 656-658
a=12.1630(10)Å b=11.3590(10)Å c=10.309(2)Å
α=90.00° β=113.580(10)° γ=90.00°
1,2-di(o-methyl-phenyl)-3,3-(oxydiethyl)-guanidine hydrochloride monohydrate
C19H24N3O,Cl,H2O
Acta Crystallographica Section C (1996) 52, 12 3238-3240
a=7.970(2)Å b=14.544(3)Å c=16.502(4)Å
α=90.00° β=100.58(5)° γ=90.00°
1,2-bis(2,6-diethylphenyl)-3,3-(oxydiethyl)guanidine
C25H35N3O
Acta Crystallographica Section C (1997) 53, 1 88-90
a=14.978(3)Å b=16.703(3)Å c=18.847(3)Å
α=90.00° β=90.00° γ=90.00°
C19H23N3OS
C19H23N3OS
Acta Crystallographica Section C (1996) 52, 8 2047-2049
a=11.773(3)Å b=11.408(1)Å c=14.830(3)Å
α=90° β=112.32(2)° γ=90°
C18H23ClN2O8
C18H23ClN2O8
Acta Crystallographica Section C (1997) 53, 11 1711-1713
a=5.3907(11)Å b=12.680(2)Å c=29.152(5)Å
α=90.00° β=90.00° γ=90.00°
1,2-diphenyl-3-benzyl-guanidine hydrochloride
C20H20N3,Cl
Acta Crystallographica Section C (1997) 53, 1 86-88
a=7.9656(11)Å b=9.7996(10)Å c=12.036(2)Å
α=86.45(2)° β=80.28(2)° γ=77.45(2)°
1-Morpholinyl-3-phenylthiourea.
C11H14N2OS
Acta Crystallographica Section C (1996) 52, 5 1285-1288
a=27.858(5)Å b=8.094(2)Å c=9.951(2)Å
α=90.00° β=90.00° γ=90.00°
1-Morpholinyl-3-tolylthiourea.
C12H16N2OS
Acta Crystallographica Section C (1996) 52, 5 1285-1288
a=40.201(5)Å b=7.5900(10)Å c=7.8290(10)Å
α=90.00° β=90.00° γ=90.00°
C17H19N3O
C17H19N3O
Acta Crystallographica Section C (1995) 51, 11 2329-2331
a=9.211(4)Å b=14.671(4)Å c=11.533(4)Å
α=90° β=111.14(4)° γ=90°
C22H26N4O2S
C22H26N4O2S
Acta Crystallographica Section C (1995) 51, 11 2323-2325
a=14.928(3)Å b=14.999(2)Å c=18.952(2)Å
α=90° β=90° γ=90°
3,5-Bis(4-methylbenzylidene)-4-oxopiperidine-1-carbonitrile
C22H20N2O
Acta Crystallographica Section E (2007) 63, 9 o3749-o3749
a=9.1976(2)Å b=9.5012(2)Å c=10.9418(3)Å
α=104.03(2)° β=95.0800(10)° γ=108.730(10)°
1-(4-Chlorophenyl)-8-(4-fluorophenyl)-4-[(<i>E</i>)-(4- fluorophenyl)methylidene]-6-methyl-4,5,6,7,7a,8-hexahydro- 1,2,4-oxadiazolo[5,4-<i>d</i>]pyrido[3,4-<i>c</i>][1,5]benzothiazepine
C33H26ClF2N3OS
Acta Crystallographica Section E (2007) 63, 11 o4268-o4268
a=10.836(5)Å b=11.366(4)Å c=23.100(3)Å
α=90.0° β=92.630(10)° γ=90.0°
8-[(<i>E</i>)-4-Methoxybenzylidene]-4-(4-Methoxyphenyl)-3- (3-phenyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydro-4<i>H</i>-chromen-2-amine
C32H29N3O4
Acta Crystallographica Section E (2007) 63, 9 o3750-o3750
a=10.5014(3)Å b=11.3187(4)Å c=11.6458(4)Å
α=91.07(2)° β=98.45(2)° γ=104.10(3)°
[3-Methyl-4-(4-methylphenyl)-1-phenyl-6-trifluoromethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-5-yl](thiophen-2-yl)methanone
C26H18F3N3OS
Acta Crystallographica Section C (2013) 69, 4 412-415
a=10.0323(4)Å b=10.3715(5)Å c=11.7411(5)Å
α=109.211(2)° β=96.105(2)° γ=95.676(2)°
[4-(4-Chlorophenyl)-3-methyl-1-phenyl-6-trifluoromethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-5-yl](thiophen-2-yl)methanone
C25H15ClF3N3OS
Acta Crystallographica Section C (2013) 69, 4 412-415
a=10.0018(7)Å b=10.3503(8)Å c=11.6309(10)Å
α=108.607(4)° β=95.295(4)° γ=95.628(4)°
(9-Fluoro-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol
C11H8FNO3
Acta Crystallographica Section C (2012) 68, 8 o288-o293
a=14.1516(2)Å b=7.00640(10)Å c=18.3134(2)Å
α=90.00° β=90.00° γ=90.00°
(9-Chloro-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol
C11H8ClNO3
Acta Crystallographica Section C (2012) 68, 8 o288-o293
a=9.43060(10)Å b=14.8892(2)Å c=21.4949(2)Å
α=98.7640(10)° β=97.6100(10)° γ=94.0130(10)°
(4<i>H</i>-Chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol
C11H9NO3
Acta Crystallographica Section C (2012) 68, 11 o481-o484
a=9.6423(2)Å b=8.34060(10)Å c=13.1461(2)Å
α=90.00° β=121.2180(10)° γ=90.00°
(8-Methyl-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol monohydrate
C12H11NO3,H2O
Acta Crystallographica Section C (2012) 68, 11 o481-o484
a=31.2492(5)Å b=4.67140(10)Å c=17.3083(4)Å
α=90.00° β=121.030(2)° γ=90.00°
1-Acetylpyrrolidine-2-carboxylic acid monohydrate
C7H11NO3,H2O
Acta Crystallographica Section C (2013) 69, 11 1390-1396
a=6.2876(3)Å b=10.7132(5)Å c=6.7764(3)Å
α=90.00° β=111.1430(10)° γ=90.00°
<i>N</i>-Benzyl-<i>L</i>-proline
C12H15NO2
Acta Crystallographica Section C (2013) 69, 11 1390-1396
a=8.7552(7)Å b=10.6254(8)Å c=11.2816(8)Å
α=90.00° β=93.737(2)° γ=90.00°
4'-(2,4-Dichlorophenyl)-1,1'-dimethylpiperidine-3-spiro-3'- pyrrolidine-2'-spiro-3''-indoline-4,2''-dione
C23H23Cl2N3O2
Acta Crystallographica Section E (2010) 66, 3 o717
a=7.9398(2)Å b=10.8747(3)Å c=13.5367(4)Å
α=66.561(2)° β=77.8730(10)° γ=83.203(2)°
Ethyl 4-(3-hydroxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline- 3-carboxylate
C21H25NO4
Acta Crystallographica Section E (2009) 65, 11 o2664
a=10.8721(4)Å b=16.1255(7)Å c=11.0856(4)Å
α=90.00° β=100.682(2)° γ=90.00°
8-(2-Chlorophenyl)-1-(4-chlorophenyl)-4-[(<i>E</i>)-(2- chlorophenyl)methylidene]-6-methyl-4,5,6,7,7a,8-hexahydro- 1,2,4-oxadiazolo[5,4-<i>d</i>]pyrido[3,4-<i>c</i>][1,5]benzothiazepine
C33H26Cl3N3OS
Acta Crystallographica Section E (2010) 66, 5 o1119
a=11.015(3)Å b=11.758(4)Å c=11.988(4)Å
α=78.87(2)° β=86.89(3)° γ=78.29(2)°
1H-imidazole
C18H17FN2
Acta Crystallographica Section E (2010) 66, 7 o1703
a=9.8888(2)Å b=7.66930(10)Å c=20.1017(3)Å
α=90° β=95.9150(10)° γ=90°
1H-imidazole
C19H20N2,0.5(H2O)
Acta Crystallographica Section E (2010) 66, 11 o2776
a=16.7611(2)Å b=11.5467(2)Å c=16.6563(2)Å
α=90° β=90° γ=90°
1H-imidazole
C18H18N2
Acta Crystallographica Section E (2010) 66, 11 o2826
a=9.6971(3)Å b=7.5458(2)Å c=19.8407(7)Å
α=90° β=96.604(3)° γ=90°
1H-imidazole
C27H19FN2
Acta Crystallographica Section E (2010) 66, 10 o2519
a=10.1794(5)Å b=10.5239(6)Å c=10.6175(6)Å
α=80.750(5)° β=85.776(4)° γ=67.348(5)°
2-Amino-4-(4-chlorophenyl)-5,6,7,8,9,10-hexahydrobenzo[8]annulene-1,3- dicarbonitrile
C20H18ClN3
Acta Crystallographica Section E (2012) 68, 9 o2692
a=11.3835(9)Å b=16.9840(13)Å c=18.4766(14)Å
α=90.00° β=90.00° γ=90.00°
2-(2,4-Difluorophenyl)-4,5-dimethyl-1-(4-methylphenyl)-1<i>H</i>-imidazole monohydrate
C18H16F2N2,H2O
Acta Crystallographica Section E (2013) 69, 11 o1599-o1600
a=7.9424(9)Å b=14.5238(16)Å c=14.6561(16)Å
α=75.087(2)° β=89.990(2)° γ=86.012(2)°
1H-imidazole
C19H19FN2
Acta Crystallographica Section E (2011) 67, 5 o1065
a=8.4226(10)Å b=9.5572(10)Å c=11.0351(11)Å
α=105.423(9)° β=105.677(9)° γ=95.781(9)°
[4-(2-Methoxyphenyl)-3-methyl-1-phenyl-6-trifluoromethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-5-yl](thiophen-2-yl)methanone
C26H18F3N3O2S
Acta Crystallographica Section E (2014) 70, 9 o974-o975
a=18.9343(11)Å b=11.6347(6)Å c=20.9800(12)Å
α=90° β=92.511(2)° γ=90°
4-Sulfamoylanilinium dihydrogen phosphate
C6H9N2O2S,H2O4P
Acta Crystallographica Section E (2014) 70, 9 o997-o998
a=4.8041(7)Å b=10.8564(15)Å c=10.3862(15)Å
α=90° β=101.067(2)° γ=90°
Bis(1,2,3,4-tetrahydroquinoline-1-thiocarbonyl) disulfide
C20H20N2S4
Acta Crystallographica Section E (2012) 68, 12 o3446
a=8.1019(4)Å b=20.3208(11)Å c=12.3647(6)Å
α=90.00° β=104.371(2)° γ=90.00°
5-Benzoyl-2-(1<i>H</i>-indol-3-yl)-4-[4-(propan-2-yl)phenyl]-4,5-dihydrofuran- 3-carbonitrile
C29H24N2O2
Acta Crystallographica Section E (2012) 68, 12 o3441
a=17.1073(4)Å b=8.1230(2)Å c=17.6160(4)Å
α=90.00° β=110.3250(10)° γ=90.00°
4-Cyano-<i>N</i>-ethylspiro[chromene-2,4'-piperidine]-1'-carboxamide
C17H19N3O2
Acta Crystallographica Section E (2013) 69, 1 o138
a=22.7845(8)Å b=14.3370(5)Å c=9.8442(3)Å
α=90.00° β=90.7830(10)° γ=90.00°
1-Methyl-1'-(4-methylphenyl)-2',3',5',6',7',7a'-hexahydro-1'<i>H</i>- dispiro[piperidine-3,2'-pyrrolizine-3',3''-indoline]-4,2''-dione
C26H29N3O2
Acta Crystallographica Section E (2012) 68, 9 o2772-o2773
a=8.7516(4)Å b=12.4649(5)Å c=21.4605(8)Å
α=97.654(2)° β=101.024(2)° γ=102.345(2)°
1'-Benzylspiro[chromene-2,4'-piperidine]-4-carbonitrile
C21H20N2O
Acta Crystallographica Section E (2012) 68, 9 o2732
a=15.1666(9)Å b=10.0472(6)Å c=12.4360(8)Å
α=90.00° β=113.931(2)° γ=90.00°
5-(4-Fluorobenzylidene)-4'-(4-fluorophenyl)-1,1'- dimethyldispiro[piperidine-3,3'-pyrrolidine-2',3''-indoline]-4,2''-dione
C30H27F2N3O2
Acta Crystallographica Section E (2012) 68, 10 o2839-o2840
a=27.1839(15)Å b=10.2809(5)Å c=18.7045(11)Å
α=90.00° β=107.920(10)° γ=90.00°
N-Boc-L-pyroglutamic acid ethyl ester
C12H19NO5
Acta Crystallographica Section E (2013) 69, 4 o567-o568
a=26.6884(13)Å b=5.7650(3)Å c=8.7054(4)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Fluorophenyl)-1-(3-methoxyphenyl)-4,5-dimethyl-1<i>H</i>-imidazole
C18H17FN2O
Acta Crystallographica Section E (2014) 70, 1 o14
a=8.1196(5)Å b=9.6014(6)Å c=10.6116(6)Å
α=106.818(3)° β=92.059(3)° γ=96.114(3)°
Benzimidazole
C23H16N2,0.5(C6H6)
Acta Crystallographica Section E (2014) 70, 1 o55-o56
a=8.5529(3)Å b=9.4517(3)Å c=11.8936(3)Å
α=86.334(2)° β=89.838(2)° γ=75.051(3)°
9-(2,4-Difluorophenyl)-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahydro-2<i>H</i>-xanthene-1,8-dione
C23H24F2O3
Acta Crystallographica Section E (2014) 70, 3 o276-o277
a=9.6810(4)Å b=10.4290(4)Å c=11.8840(5)Å
α=69.288(2)° β=74.895(2)° γ=63.406(2)°
<i>N</i>-<i>tert</i>-Butoxycarbonyl-α-(2-fluorobenzyl)-<i>L</i>-proline
C17H22FNO4
Acta Crystallographica Section E (2013) 69, 8 o1297
a=10.47770(10)Å b=12.4283(2)Å c=13.1550(2)Å
α=90.00° β=90.00° γ=90.00°
1-(3-Methoxyphenyl)-4,5-dimethyl-2-phenyl-1<i>H</i>-imidazole
C18H18N2O
Acta Crystallographica Section E (2013) 69, 7 o1154
a=8.01990(10)Å b=9.48070(10)Å c=10.4971(2)Å
α=108.3390(10)° β=94.9100(10)° γ=90.5350(10)°
1'-Methyl-5''-(2-methylbenzylidene)-4'-(2-methylphenyl)dispiro[acenaphthene-1,2'-pyrrolidine-3',3''-piperidine]-2,4''-dione
C36H34N2O2
Acta Crystallographica Section E (2019) 75, 10 1456-1462
a=8.7507(5)Å b=15.9089(8)Å c=20.2879(10)Å
α=90° β=92.935(2)° γ=90°